Sumitomo Dainippon Pharma Co Ltd - Free Cash Flow To Equity
Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.
The indicator "Free-Cash-Flow-To-Equity" stands at -9.00 Billion Japanese Yens as of 12/31/2024, the lowest value at least since 12/31/2017, the period currently displayed. Regarding the Three-Year-Change of the series, the current value constitutes a decrease of -7.75 percent compared to the value three years prior.
The 3 year change in percent is -7.75.
The 5 year change in percent is -319.16.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2024, to it's latest available value, on 12/31/2024, is +0.0 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 12/31/2019, to it's latest available value, on 12/31/2024, is -319.16 Billion.
Free Cash Flow To Equity for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Free Cash Flow To Equity | 905,699,262,464.00 |
 | Johnson & Johnson - Free Cash Flow To Equity | 486,508,953,600.00 |
 | AbbVie Inc - Free Cash Flow To Equity | 399,570,305,024.00 |
 | Roche Holding AG - Free Cash Flow To Equity | 317,433,206,677.55 |
 | AstraZeneca PLC - Free Cash Flow To Equity | 280,205,508,085.11 |